Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

iwCLL 2023 | Comprehensive geriatric assessments can aid in selecting treatment for elderly patients with CLL

Raúl Córdoba • 7 Oct 2023
iwCLL 2023
Chronic Lymphocytic Leukemia Leukemia Ibrutinib Venetoclax
GLOW

Raul Cordoba, MD, PhD, University Hospital Fundación Jiménez Díaz, Madrid,
Spain, discusses the need for comprehensive geriatric assessments to determine the best treatment strategies for elderly and frail patients with chronic lymphocytic leukemia (CLL). This interview took place at the 20th International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Biennial Meeting, held in Boston, MA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Raúl Córdoba

2:08
The differences in outcomes and treatment in CLL patients with mutated and unmutated IGHV
Raúl Córdoba • 7 Oct 2023
2:12
Real-world safety and efficacy of first- and second-generation BTK inhibitors in CLL
Raúl Córdoba • 7 Oct 2023
2:20
Clinical relevance of geriatric assessment
Raúl Córdoba • 22 Jun 2020
1:36
Relative dose intensity in older DLBCL patients
Raúl Córdoba • 22 Jun 2020

Related Videos

1:40
The role of CPX-351 in the AML treatment landscape & insights into the AMLSG 30-18 trial
Felicitas Thol • 19 Apr 2024
3:21
Integrating genomics and MRD in transplant decision-making for patients with AML
Jurjen Versluis • 22 Apr 2024
4:19
Blinatumomab to achieve remission and consolidation with haploSCT for pediatric ALL
Alberto Olaya-Vargas • 15 Apr 2024
3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals